Five blood markers, among them p-tau217, were measured in 818 adults who had no cognitive symptoms, then set against 2,293 later MRI scans. Over follow-up 104 developed mild cognitive impairment or dementia, 74 of them from Alzheimer's disease. p-tau217 was associated with those Alzheimer's cases, and with shrinkage in the brain areas typical of Alzheimer's, but not with the shrinkage of ordinary ageing.
Why it is interesting: Separates shrinkage specific to Alzheimer's from the shrinkage of ordinary ageing, in people still free of symptoms.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.